Key Client Fiduciary Advisors »

Leap Therapeutics shares owned by Key Client Fiduciary Advisors

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Key Client Fiduciary Advisors from 13F filings

Historical chart of Key Client Fiduciary Advisors investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Key Client Fiduciary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Key Client Fiduciary Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $827k 322k 2.57
2024-06-30 $558k 285k 1.96
2024-03-31 $620k 233k 2.66
2023-12-31 $890k 215k 4.15
2023-09-30 $314k 227k 1.38
2023-06-30 $496k 159k 3.13

More positions owned by Key Client Fiduciary Advisors

First Tr Exchange-traded Risng Divd Achiv (RDVY)
Apple (AAPL)
Microsoft Corporation (MSFT)
First Tr Exchange Traded Indxx Aerospace (MISL)
First Tr Morningstar Divid L SHS (FDL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Amazon (AMZN)
Oracle Corporation Put Option (ORCL)
Select Sector Spdr Tr Sbi Int-utils (XLU)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange Traded Consumr Staple (FXG)
Annaly Capital Management In Com New (NLY)
Wal-Mart Stores (WMT)

View all positions for Key Client Fiduciary Advisors

Top funds holding Leap Therapeutics

Balyasny Asset Management
Samsara BioCapital
683 Capital Management
Rock Springs Capital Management
Baker Bros. Advisors
Simplify Asset Management
Vanguard Group
Laurion Capital Management
Citadel Advisors
Geode Capital Management
Key Client Fiduciary Advisors
BlackRock
Acadian Asset Management
BlackRock
Dimensional Fund Advisors

View all funds holding Leap Therapeutics